• Home
  • About
    • Psychedelic For Healthy People
    • Psilocybin (Magic Mushrooms)
    • Ayahuasca (Chacruna – Kaapi – Yajé)
    • MDMA (MDA – Sassafras)
    • Peyote Mescaline (Huachuma)
    • Kambo – Amazonian Frog
    • 5-MeO-DMT (Toad Medicine)
    • Rapé And Sacred Tobacco
    • Iboga (Ibogaine)
    • LSD (Lysergic Acid Diethylamide)
    • Cannabis (Marijuana)
    • Ketamine
    • Psychedelic Integration
    • Psychedelics Advocates
    • Frequently Asked Questions
    • Mental Health Symptoms
    • Substances Test Kits
    • Manifesto
  • Treatments
    • Latest Psychedelic Research
    • Addiction
    • Alcoholism
    • Anxiety
    • Bipolar Disorder
    • Cancer
    • Cluster Headaches
    • Depression
    • End Of Life
    • OCD
    • Neuropathy
    • Pain
    • Parkinson’s Disease
    • PTSD
    • Smoking
    • Help Treat Mental Illness
  • Microdosing
    • What is Microdosing?
    • Microdosing Magic Mushrooms
    • Microdosing LSD
    • Microdosing MDMA
    • Microdosing Ayahuasca
    • Microdosing Mescaline
    • Microdosing Cannabis
    • Microdosing Ibogaine
  • Resources
    • Past Events
    • ALL Locations
    • DMT Psychoactive Plants
    • Medical Trials And Research
    • Psychedelic Research
    • EntheoPodcasts
    • In The News
    • Books On Psychedelics
    • Related Videos
    • EntheoResources
    • Terence McKenna
    • What Is Psychedelic Art?
    • Useful Links
    • Movies & Documentaries
    • Michael Pollan
Contact
  • Follow
  • Follow
  • Follow
  • Follow

US voters embrace landmark drug reform measures in 2020 election

by EmpathiCSubstanceS | Apr 25, 2021 | Psychedelic Medicine

While the 2020 US election has turned into a nail-biter with a deeply partisan divide splitting the country with razor-thin margins, a broad array of ballot measures relating to drug reform have turned out to be some of the only things Americans seem to agree on. A...

How psychedelic DMT promotes the production of new brain cells

by EmpathiCSubstanceS | Apr 25, 2021 | Cannabis Marijuana

Robust new research, published in the journal Translational Psychiatry, is reporting on several years of animal studies showing how a psychedelic drug called dimethyltryptamine (DMT) can promote brain plasticity and induce the formation of new neurons. The research...

Psilocybin & migraine: First of its kind trial reports promising results

by EmpathiCSubstanceS | Apr 25, 2021 | Addiction, Cannabis Marijuana

A first-of-its-kind exploratory study, led by researchers from Yale School of Medicine, has found a single dose of the psychedelic psilocybin can reduce migraine frequency by 50 percent for a least two weeks. The preliminary trial was small, with follow-up work...

World-first cannabis study finds CBD alone doesn’t impair driving ability

by EmpathiCSubstanceS | Apr 25, 2021 | Cannabis Marijuana

A novel study investigating the effects of cannabis on driving in a real-world context has found cannabidiol (CBD) alone does not impair driving ability. The landmark finding promises to be invaluable in guiding road safety regulations as cannabis laws shift across...

MDMA-assisted couples therapy investigated in landmark pilot trial

by EmpathiCSubstanceS | Apr 25, 2021 | MDMA Sassafras Molly

In the late 1970s and early 1980s MDMA was often utilized to help facilitate positive results in couples counseling. A few dozen pioneering psychotherapists in the United States explored the drug’s therapeutic uses until the US government declared MDMA a Schedule 1...
« Older Entries
Next Entries »

IMPORTANT NOTICE:

This community is being designed as a secure space. It is not a place to seek, encourage, or participate in the procurement of controlled substances. Do not bring, buy, sell, transfer, or arrive on any illegal substances, or swap information on how to buy them. Attendees and/or members of this community who violate these basic house rules will be removed from the community and will not be allowed to attend future events.

Psychedelic Research

Psilocybin with psychological support for treatment-resistant depression: An open-label feasibility study

Aug 11, 2022

Psilocybin's acute psychedelic effects typically became detectable 30-60 min after dosing, peaked 2-3 h after dosing, and subsided to negligible levels at least 6 h after dosing. Mean self-rated intensity (on a 0-1 scale) was 0·51 (SD 0·36) for the low-dose session...

Potential Psychiatric Uses for MDMA

Aug 11, 2022

In MDMA studies, participants report improved self‐knowledge, sleep regulation, accuracy in perceiving mental states of others, coping strategies, emotion regulation, and cognitive insights. Objective measures support attenuated impact of social rejection and reduced...

The cognitive effects of 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) are associated with improvements in depression and anxiety conditions

Aug 11, 2022

Of those reporting a history of being diagnosed with depression (n=149; 41%) or anxiety (n=173; 48%), most reported symptoms were improved (depression=81%; anxiety=79%) following 5-MeO-DMT use and relatively fewer reported symptoms remained the same (depression=17%;...

Psychedelic Medicine

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

© 2025| All Rights Reserved, EntheoMedicine Community
  • Follow
  • Follow
  • Follow
  • Follow